Hemolytic Anemias Resulting from Extracellular Factors—Immune Hemolytic Anemias

Published on 22/03/2015 by admin

Filed under Pediatrics

Last modified 22/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1293 times

Chapter 458 Hemolytic Anemias Resulting from Extracellular Factors—Immune Hemolytic Anemias

Autoimmune Hemolytic Anemias

A number of extrinsic agents and disorders may lead to premature destruction of red blood cells (RBCs) (Table 458-1). Among the most clearly defined are antibodies associated with immune hemolytic anemias. The hallmark of this group of diseases is the positive result of the direct antiglobulin (Coombs) test, which detects a coating of immunoglobulin or components of complement on the RBC surface. The most important immune hemolytic disorder in pediatric practice is hemolytic disease of the newborn (erythroblastosis fetalis), caused by transplacental transfer of maternal antibody active against the RBCs of the fetus, that is, isoimmune hemolytic anemia (Chapter 97.2). Various other immune hemolytic anemias are autoimmune (see Table 458-1) and may be idiopathic or related to various infections (Epstein-Barr virus, rarely HIV, cytomegalovirus, and mycoplasma), immunologic diseases (systemic lupus erythematosus [SLE], rheumatoid arthritis), immunodeficiency diseases (agammaglobulinemia, autoimmune lymphoproliferative disorder, dysgammaglobulinemias), neoplasms (lymphoma, leukemia, and Hodgkin disease), or drugs (methyldopa, L-dopa). Other drugs (penicillins, cephalosporins) cause hemolysis by means of “drug-dependent antibodies—that is antibodies directed toward the drug and in some cases toward an RBC membrane antigen as well.

Autoimmune Hemolytic Anemias Associated With “Warm” Antibodies


In the autoimmune hemolytic anemias, abnormal antibodies are directed against RBC membrane antigens, but the pathogenesis of antibody induction is uncertain. The autoantibody may be produced as an inappropriate immune response to an RBC antigen or to another antigenic epitope similar to an RBC antigen, known as molecular mimicry. Alternatively, an infectious agent may alter the RBC membrane so that it becomes “foreign” or antigenic to the host. The antibodies usually react to epitopes (antigens) that are “public” or common to all human RBCs, such as Rh proteins.

In most instances of warm antibody hemolysis, no underlying cause can be found; this is the primary or idiopathic type (see Table 458-1). If the autoimmune hemolysis is associated with an underlying disease, such as a lymphoproliferative disorder, SLE, or immunodeficiency, it is secondary. In as many as 20% of cases of immune hemolysis, drugs may be implicated (Table 458-2).

Drugs (penicillin or sometimes cephalosporins) that cause hemolysis via the “hapten” mechanism (immune but not autoimmune) bind tightly to the RBC membrane (see Table 458-1). Antibodies to the drug, either newly or previously formed, bind to the drug molecules on RBCs, mediating their destruction in the spleen. In other cases, certain drugs, such as quinine and quinidine, do not bind to RBCs but, rather, form part of a “ternary complex,” consisting of the drug, an RBC membrane antigen, and an antibody that recognizes both (see Table 458-1

Buy Membership for Pediatrics Category to continue reading. Learn more here